Claris Settles Litigation with Fresenius Kabi on 'Diprivan'

Drug-maker Claris Lifesciences on Monday said it has settled 'litigation and licence agreement' with US-based Fresenius Kabi to sell generic version of anesthesia drug, Diprivan, in the US. In a BSE filing, Claris Lifesciences said "... has reached a settlement and licence agreement, ending all pending litigation with Fresenius Kabi, USA Inc. with reference to the alleged infringement of a patent related to Propofol." In December 2...